Insilico Medicine has entered a strategic partnership with Qilu Pharmaceutical to develop treatments for cardiometabolic ...

Other countries in Europe to lose eliminated status include Armenia, Austria, Azerbaijan, Spain, and Uzbekistan. Sustained ...

The lack of initial public offerings (IPOs) also reflects a year of restricted growth. As per the BIA, no UK biotechs went ...

A new report has revealed that 83% of life sciences CEOs view Internet of Medical Things (IoMT) devices as the most important capability towards driving growth, accelerating R&D, and unlocking ...

With a market cap of around $23bn, Revolution has seen its stock climb over the year on the back of its promising oncology portfolio. Credit: Tada Images via Shutterstock.com. Merck & Co (MSD) is no ...

Eisai and Biogen have announced that the US FDA has accepted for review the sBLA submitted by the former for Leqembi Iqlik SC ...

Bristol Myers Squibb (BMS) has entered into an agreement with Microsoft to advance AI-driven early lung cancer detection.

Corxel Pharmaceuticals has raised $287m to fund its suite of cardiometabolic assets, signifying that investor appetite for ...

Novartis has announced that the FDA has granted a breakthrough therapy designation to ianalumab, a treatment for Sjögren’s ...

AstraZeneca has agreed to buy AbelZeta’s 50% stake in the China development and commercialisation rights for C-CAR031.

The key element of the agreement is confirmation that UK pharmaceutical exports to the US will face a preferential tariff ...